Varicella, Varivax® CDC Federal Contract Number: 75D30125D00195, Manufacturer: Merck (MRK). Program, (Immunizations, Vaccine Services Group) Texas…

Merck Sharp & Dohme Corp has been awarded a contract by the State of Texas under contract identification number HHSTX-6-0000397144, effective March 11, 2026. This contract is aligned with the federal CDC Federal Contract Number 75D30125D00195 and falls under the Texas Immunizations Vaccine Services Group program governed by Texas Government Code Section 2155.144. The primary product being procured is Varicella vaccine (Varivax), manufactured by Merck, which is utilized for immunization services delivered through the state's vaccine program.

The contract is classified under the National Institute of Governmental Purchasing (NIGP) category for Serums, Toxoids, and Vaccines (NIGP 26980). The United Nations Standard Products and Services Code classifications associated with this award include vaccine-related categories, consistent with the immunomodulating and vaccine nature of the deliverables. While specific contract value amounts, annual value figures, and the detailed period of performance are not populated in the award documentation provided, this procurement represents Texas's acquisition of varicella immunization products to support the state's vaccine services operations.